Obesity
Products Related to Obesity(118)
- GC5239810-oxo-12(Z)-Octadecenoic Acid ethyl esterPurity: >95.00%
An ester form of 10-oxo-12(Z)-octadecenoic acid
- GC5242810-oxo-12(Z)-Octadecenoic Acid-d5Purity: >99.00%
An internal standard for the quantification of 10-oxo-12(Z)-octadecenoic acid
- GC52453Orexin A (17-33) (human, mouse, rat, bovine) (trifluoroacetate salt)Purity: >98.00%
A peptide orexin receptor 1 agonist
- GC52507Orexin A amide (bovine, human, mouse, rat) (trifluoroacetate salt)Purity: >95.00%
A hypothalamic neuropeptide
- GC72096BamadutideCAS: 1596343-09-7Purity: >99.00%
Bamadutide (SAR425899) is a potent dual glucagon-like peptide-1 receptor/glucagon receptor agonist.
- GC72222SurvodutideCAS: 2805997-46-8Purity: >99.50%
Survodutide (BI 456906) is a potent, selective glucagon receptor/GLP-1 receptor (GCGR/GLP-1R) dual agonist with EC50s of 0.52 nM and 0.33 nM in CHO-K1 cells, respectively.
- GC91449Ipamorelin (acetate)Purity: >98.00%
Ipamorelin is a pentapeptide growth hormone secretagogue (GHS) and GHS receptor 1a (GHS-R1a) agonist.
- GC92088GLP-1 (28-36) amide (trifluoroacetate salt)Purity: >98.00%
Glucagon-like peptide 1 (GLP-1) (28-36) amide is a peptide and an active metabolite of the endogenous GLP-1R agonist GLP-1 (7-36) amide.
- GC92095Ac-(D-Arg)-CEH-(D-Phe)-RWC-NH2 (trifluoroacetate salt)Purity: >98.00%
Ac-(D-Arg)-CEH-(D-Phe)-RWC-NH2 is a cyclic peptide and an agonist of melanocortin receptor 4 (MC4R).
- GC92118Taspoglutide (acetate)CAS: 1022150-16-8Purity: >98.00%
Taspoglutide is an agonist of the glucagon-like peptide 1 receptor (GLP-1R; Ki = 1.1 nM for the human receptor).
- GC92119GLP-1 (7-36) acid (human, mouse, rat, porcine, bovine)Purity: >98.00%
Glucagon-like peptide 1 (GLP-1) (7-36) acid is a derivative of the hormone and GLP-1 receptor (GLP-1R) agonist GLP-1 (7-36) amide.
- GC92122KBP-066 (trifluoroacetate salt)Purity: >95.00%
KBP-066 is a dual amylin and calcitonin (CT) receptor agonist.
- GC92125Liraglutide (acetate)CAS: 1997361-86-0Purity: >95.00%
Liraglutide is a potent agonist of the glucagon-like peptide 1 (GLP-1) receptor and a synthetic derivative of GLP-1 (7-37) that contains a palmitic acid group.
- GC92131NN1177 (trifluoroacetate salt)Purity: >98.00%
NN1177 is a dual peptide agonist of the glucagon receptor (GCGR) and glucagon-like peptide 1 receptor (GLP-1R).
- GC92132SAR441255 (sodium salt)Purity: >95.00%
SAR441255 is a peptide triple agonist of the glucagon-like peptide 1 receptor (GLP-1R), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon receptor (GCGR).
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC52398 | 10-oxo-12(Z)-Octadecenoic Acid ethyl ester | - | >95.00% | |
An ester form of 10-oxo-12(Z)-octadecenoic acid | ||||
| GC52428 | 10-oxo-12(Z)-Octadecenoic Acid-d5 | - | >99.00% | |
An internal standard for the quantification of 10-oxo-12(Z)-octadecenoic acid | ||||
| GC52453 | Orexin A (17-33) (human, mouse, rat, bovine) (trifluoroacetate salt) | - | >98.00% | |
A peptide orexin receptor 1 agonist | ||||
| GC52493 | Glucosylceramide (bovine buttermilk) | - | >98.00% | |
A sphingolipid | ||||
| GC52497 | Lactosylceramide (porcine RBC) | - | >98.00% | |
A sphingolipid | ||||
| GC52502 | Peptide YY (3-36) (trifluoroacetate salt) | - | >95.00% | |
A satiety hormone | ||||
| GC52506 | Ghrelin (human) (trifluoroacetate salt) | - | >98.00% | |
A growth hormone releasing peptide | ||||
| GC52507 | Orexin A amide (bovine, human, mouse, rat) (trifluoroacetate salt) | - | >95.00% | |
A hypothalamic neuropeptide | ||||
| GC69439 | Mazdutide | 2259884-03-0 | >99.00% | |
Mazdutide is a long-acting dual agonist of the glucagon-like peptide-1 receptor (GLP-1R; K i =28.6nM) and the glucagon receptor (GCGR; K i =17.7nM). | ||||
| GC72096 | Bamadutide | 1596343-09-7 | >99.00% | |
Bamadutide (SAR425899) is a potent dual glucagon-like peptide-1 receptor/glucagon receptor agonist. | ||||
| GC72222 | Survodutide | 2805997-46-8 | >99.50% | |
Survodutide (BI 456906) is a potent, selective glucagon receptor/GLP-1 receptor (GCGR/GLP-1R) dual agonist with EC50s of 0.52 nM and 0.33 nM in CHO-K1 cells, respectively. | ||||
| GC90496 | β-Cortolone | 667-66-3 | >95.00% | |
A metabolite of cortisol | ||||
| GC91449 | Ipamorelin (acetate) | - | >98.00% | |
Ipamorelin is a pentapeptide growth hormone secretagogue (GHS) and GHS receptor 1a (GHS-R1a) agonist. | ||||
| GC91966 | Ppc-1 | 1245818-17-0 | - | |
Ppc-1 is a prenylated quinolinecarboxylic acid originally isolated from P. pseudo-candidum that has diverse biological activities. | ||||
| GC92088 | GLP-1 (28-36) amide (trifluoroacetate salt) | - | >98.00% | |
Glucagon-like peptide 1 (GLP-1) (28-36) amide is a peptide and an active metabolite of the endogenous GLP-1R agonist GLP-1 (7-36) amide. | ||||
| GC92095 | Ac-(D-Arg)-CEH-(D-Phe)-RWC-NH2 (trifluoroacetate salt) | - | >98.00% | |
Ac-(D-Arg)-CEH-(D-Phe)-RWC-NH2 is a cyclic peptide and an agonist of melanocortin receptor 4 (MC4R). | ||||
| GC92118 | Taspoglutide (acetate) | 1022150-16-8 | >98.00% | |
Taspoglutide is an agonist of the glucagon-like peptide 1 receptor (GLP-1R; Ki = 1.1 nM for the human receptor). | ||||
| GC92119 | GLP-1 (7-36) acid (human, mouse, rat, porcine, bovine) | - | >98.00% | |
Glucagon-like peptide 1 (GLP-1) (7-36) acid is a derivative of the hormone and GLP-1 receptor (GLP-1R) agonist GLP-1 (7-36) amide. | ||||
| GC92122 | KBP-066 (trifluoroacetate salt) | - | >95.00% | |
KBP-066 is a dual amylin and calcitonin (CT) receptor agonist. | ||||
| GC92125 | Liraglutide (acetate) | 1997361-86-0 | >95.00% | |
Liraglutide is a potent agonist of the glucagon-like peptide 1 (GLP-1) receptor and a synthetic derivative of GLP-1 (7-37) that contains a palmitic acid group. | ||||
| GC92131 | NN1177 (trifluoroacetate salt) | - | >98.00% | |
NN1177 is a dual peptide agonist of the glucagon receptor (GCGR) and glucagon-like peptide 1 receptor (GLP-1R). | ||||
| GC92132 | SAR441255 (sodium salt) | - | >95.00% | |
SAR441255 is a peptide triple agonist of the glucagon-like peptide 1 receptor (GLP-1R), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon receptor (GCGR). | ||||
